Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
复制标题
DOI:
10.1002/hed.23318
复制
发表时间:
2014-04
期刊:
影响因子:
--
通讯作者:
Chiosea SI
中科院分区:
文献类型:
--
作者:
Dogan S;Hedberg ML;Ferris RL;Rath TJ;Assaad AM;Chiosea SI
The significance of human papillomavirus (HPV) in nasopharyngeal carcinomas (NPCs) in a low-incidence population remains unknown. Samples from 90 patients with NPC (years, 1957–2012) were analyzed for Epstein–Barr virus (EBV). Clinical data, EBV, HPV, and p16 status were correlated with overall survival (OS; 63 cases; years, 1981–2012). Of 9 HPV-positive cases, 3 extended from extra-nasopharyngeal sites. Nasopharyngeal origin was confirmed in 6 cases. HPV-positive NPC had OS similar to EBV-positive NPC (85 vs 141 months; p > .05). The OS of patients with EBV/HPV-negative NPC was worse (34 months; p = .004). Nonkeratinizing histology was associated with better outcome than keratinizing (115 vs 25 months; p = .001). Over the last several decades, the proportion of keratinizing NPC decreased from 34.5% to 14.3% (p = .026). The etiologic role of HPV in NPC is confirmed. The favorable prognostic significance of HPV positivity is similar to that of EBV positivity.